12.07.2024 15:38:05
|
Fastenal Promotes Jeff Watts To Succeed Dan Florness As President; Florness To Continue As CEO
(RTTNews) - Fastenal Co. (FAST) announced Friday it has appointed Jeff Watts to the position of President, effective August 1, 2024. In addition to serving as President, Watts will continue in his role as the Company's Chief Sales Officer (CSO), a position he has held since May 2023.
Watts will succeed Dan Florness, who will be voluntarily vacating the position on the effective date. Florness will continue to serve as Fastenal's CEO and as a member of its Board of Directors.
Watts, a 28-year Company veteran with deep global sales experience, has previously served as Fastenal's Executive Vice President - International Sales, Vice President - International Sales, and Regional Vice President of the Company's Canadian business.
Prior to this, he served in a variety of sales roles on the district and local market levels. He joined the Company as a part-time branch employee on February 5, 1996.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Fastenal Co.mehr Nachrichten
10.03.25 |
NASDAQ Composite Index-Papier Fastenal-Aktie: So viel Gewinn hätte ein Investment in Fastenal von vor 10 Jahren abgeworfen (finanzen.at) | |
06.03.25 |
Schwache Performance in New York: NASDAQ 100 beendet die Sitzung im Minus (finanzen.at) | |
06.03.25 |
Schwacher Wochentag in New York: S&P 500 letztendlich schwächer (finanzen.at) | |
06.03.25 |
Angespannte Stimmung in New York: NASDAQ 100 gibt am Nachmittag nach (finanzen.at) | |
06.03.25 |
Minuszeichen in New York: So bewegt sich der S&P 500 am Nachmittag (finanzen.at) | |
06.03.25 |
Handel in New York: S&P 500 verbucht am Mittag Verluste (finanzen.at) | |
06.03.25 |
Anleger in New York halten sich zurück: NASDAQ 100 sackt mittags ab (finanzen.at) | |
06.03.25 |
Zurückhaltung in New York: NASDAQ Composite zum Handelsstart in Rot (finanzen.at) |
Analysen zu Fastenal Co.mehr Analysen
Aktien in diesem Artikel
Fastenal Co. | 70,05 | -1,75% |
|